Resultados de la búsqueda 71-80 of 21536 for Treatment

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This open-label research study is studying (Z)-endoxifen as a possible treatment for pre-menopausal women with ER+/HER2- breast cancer.

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Patients may receive a single dose to a liver lobe or segmental treatment delivered as a sequence of treatments approximately 30-90 days apart. The ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Patients may receive a single dose to a liver lobe or segmental treatment delivered as a sequence of treatments approximately 30-90 days apart. The ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). ... treatment and may reduce the burden of cancer and ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... treatment) in Breast Cancer 1/2 genes (BRCA 1/2) and PALB2 associated HER2-negative metastatic breast cancer. The names of the study drugs involved in this ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This open-label research study is studying (Z)-endoxifen as a possible treatment for pre-menopausal women with ER+/HER2- breast cancer.

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... treatment, post-treatment and (when available) post-mortem soft tissue sarcoma (STS) tissue and tissue data with an emphasis on STSs occurring in younger ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    (Z)-Endoxifen For The Treatment Of Premenopausal Women With ER+/HER2- Breast Cancer. Scottsdale/Phoenix, Ariz., Jacksonville, Fla., Rochester, Minn. This ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Patients may receive a single dose to a liver lobe or segmental treatment delivered as a sequence of treatments approximately 30-90 days apart. The ...

  10. Radiología - Ensayos clínicos - Mayo Clinic

    Patients may receive a single dose to a liver lobe or segmental treatment delivered as a sequence of treatments approximately 30-90 days apart. The ...